EVALUATION OF THE EFFECT OF SODIUM–GLUCOSE COTRANSPORTER-2 INHIBITORS IN THE TREATMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. the Conf. Hub 2025, 56-57.